US Stock MarketDetailed Quotes
SZLSF STAGEZERO LIFE SCIENCES LTD
- 0.015
- +0.014+900.00%
15min DelayClose Jul 12 16:00 ET
1.85MMarket Cap-125P/E (TTM)
0.015High0.002Low2.60KVolume0.002Open0.002Pre Close35.63Turnover0.00%Turnover RatioLossP/E (Static)123.55MShares0.05652wk High-0.18P/B1.85MFloat Cap0.00252wk Low--Dividend TTM123.55MShs Float0.061Historical High--Div YieldTTM900.00%Amplitude0.002Historical Low0.013Avg Price1Lot Size
About STAGEZERO LIFE SCIENCES LTD Company
StageZero Life Sciences Ltd. engages in the development and commercialization of proprietary molecular diagnostic tests for detection of diseases and for personalized health management, with a focus on cancer-related indications. Its products includes Sentinel Principle, and ColonSentry. The company was founded by Choong-Chin Liew and K. Wayne Marshall on February 20, 1997 and is headquartered in Richmond Hill, Canada.
Company Profile
SymbolSZLSF
Company NameSTAGEZERO LIFE SCIENCES LTD
Founded1997
CEOMr. James R. Howard-Tripp
MarketPink Market
Employees40
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address70 East Beaver Creek Road,Unit 30
CityRichmond Hill
ProvinceOntario
CountryCanada
Zip CodeL4B 3B2
Phone1-855-420-7140
Company Executives
- Name
- Position
- Salary
- James R. Howard-Tripp
- Chairman of the Board and Chief Executive Officer
- --
- Matthew Pietras
- Chief Financial Officer and Chief Operating Officer
- --
- Garth A.C. Macrae
- Independent Director
- --
- Rory B. Riggs
- Independent Director
- --
- Harry Glorikian
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
